ITGA3 Gene - Integrin Subunit Alpha 3

Key mediator of cell adhesion, migration, and signaling in epithelial and endothelial tissues

Gene Information Card

Symbol ITGA3
Full Name Integrin Subunit Alpha 3
Gene Type Protein coding
Chromosomal Location 17q21.33
NCBI Gene ID 3675 ncbi.nlm.nih.gov/gene/3675
Ensembl ID ENSG00000005884
UniProt ID P26006
OMIM ID 605025
HGNC ID 6139
Aliases CD49c, VLA3a, GAP-B3, MSK18

Description

ITGA3 encodes the integrin alpha 3 subunit, which heterodimerizes with beta 1 integrin to form the α3β1 integrin receptor (VLA-3). This receptor mediates cell adhesion to laminins, collagen, and other extracellular matrix components. ITGA3 is critical for epithelial and endothelial integrity, kidney development, lung function, and wound healing. Mutations cause interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa (ILNEB syndrome). Overexpression is linked to cancer invasion and metastasis.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa (ILNEB syndrome) Loss-of-function mutations in ITGA3 disrupt α3β1 integrin-mediated adhesion in lung, kidney, and skin epithelia, leading to organ failure. OMIM #614748; ClinVar; PMID: 22284826
Congenital nephrotic syndrome ITGA3 mutations impair glomerular basement membrane adhesion, causing proteinuria and renal failure. OMIM #605025; PMID: 22284826
Cancer (multiple types) ITGA3 overexpression promotes tumor cell adhesion, migration, and invasion via α3β1 integrin signaling, associated with poor prognosis in breast, lung, and pancreatic cancers. COSMIC; PMID: 28431213

Expression Profile

Tissue Expression
Tissue nTPM level
Lung 42.3 High
Kidney 38.1 High
Skin 35.7 High
Breast 28.9 Medium
Pancreas 22.4 Medium
Liver 8.2 Low
Cell Line Expression
Cell Line nTPM Notes
A549 (lung carcinoma) 56.2 High expression
HEK 293 (embryonic kidney) 44.8 High expression
MCF7 (breast carcinoma) 32.1 Medium expression
HaCaT (keratinocyte) 29.5 Medium expression
HepG2 (hepatocellular carcinoma) 9.3 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1871G>A (p.Arg624His) Missense Rare (ILNEB) Loss of α3β1 integrin function; disrupts ligand binding
c.1771C>T (p.Arg591*) Nonsense Rare (ILNEB) Premature truncation; loss of protein function
c.2440G>A (p.Glu814Lys) Missense Rare (ILNEB) Impaired heterodimerization with beta 1
c.959_960del (p.Leu320Profs*12) Frameshift Rare (ILNEB) Complete loss of function
Mutation functional classification

Loss of Function (LOF)

Most ILNEB-associated ITGA3 mutations are loss-of-function, leading to reduced or absent α3β1 integrin activity.

Gain of Function (GOF)

Not reported in ITGA3; gain-of-function mutations are not documented in ClinVar or COSMIC.

Dominant Negative (DN)

Not reported; ITGA3 mutations are typically recessive in ILNEB syndrome.

Pathways

Integrin signaling pathway (KEGG: hsa04510)
ECM-receptor interaction (KEGG: hsa04512)
Focal adhesion (KEGG: hsa04510)
PI3K-Akt signaling pathway (KEGG: hsa04151)

Protein Summary

Integrin alpha 3 (CD49c) is a 1106-amino acid transmembrane protein that forms the α3β1 integrin complex. It contains an extracellular domain with seven FG-GAP repeats, a transmembrane domain, and a short cytoplasmic tail. The α3β1 integrin binds primarily to laminins (e.g., laminin-332, laminin-511) and mediates cell adhesion, spreading, and migration. It is essential for the integrity of epithelial and endothelial barriers, particularly in lung, kidney, and skin. Post-translational modifications include N-glycosylation and proteolytic cleavage. UniProt ID: P26006.

Related Products

Product name Cat.No. Species Gene ID
ITGA3 Knockout HEK293 Cell Line EDJ-KQ811 Human 3675 Details Get a Quote
ITGA3 Knockout HeLa Cell Line EDJ-KQ18310 Human 3675 Details Get a Quote
ITGA3 Knockout A-549 Cell Line EDJ-KQ19554 Human 3675 Details Get a Quote
ITGA3 Knockout HCT 116 Cell Line EDJ-KQ19555 Human 3675 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: